{"transactions":[{"id":2444530,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":131625,"kind":"person","name":"Salek-Ardakani Shahram","position":1,"cik":"0001873352","reported_name":"Salek-Ardakani Shahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T17:28:46.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":114250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2023 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":114250,"derivative":{"exercise_price":20.24,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":114250},"source":{"system":"sec-edgar","filing":"0001209191-22-001833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873352/000120919122001833/doc4.xml","form_type":"4"}}]}